Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

OBJECTIVE: Coagulopathy is one of the characteristics observed in critically ill patients with coronavirus disease 2019 (COVID‐19). Antiphospholipid antibodies (aPLs) contribute to coagulopathy, though their role in COVID‐19 remains unclear. This study was undertaken to determine the prevalence and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Rheumatol
Main Authors: Xiao, Meng, Zhang, Yan, Zhang, Shulan, Qin, Xuzhen, Xia, Peng, Cao, Wei, Jiang, Wei, Chen, Huan, Ding, Xin, Zhao, Hua, Zhang, Hongmin, Wang, Chunyao, Zhao, Jing, Sun, Xuefeng, Tian, Ran, Wu, Wei, Wu, Dong, Ma, Jie, Chen, Yu, Zhang, Dong, Xie, Jing, Yan, Xiaowei, Zhou, Xiang, Liu, Zhengyin, Wang, Jinglan, Du, Bin, Qin, Yan, Gao, Peng, Lu, Minya, Hou, Xin, Wu, Xian, Zhu, Huadong, Xu, Yingchun, Zhang, Wen, Li, Taisheng, Zhang, Fengchun, Zhao, Yongqiang, Li, Yongzhe, Zhang, Shuyang
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
COVID‐19
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7361932/
https://ncbi.nlm.nih.gov/pubmed/32602200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41425
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados